Skip to content

Cerus CERS Net margin

Net margin at other companies

CorMedix logo
CorMedixCRMD
45.2%
Haemonetics logo
HaemoneticsHAE
13.3%+3.8pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
6.5%+3.4pp
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-154.9%-182pp
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-45.6%-75.7pp
ADMA Biologics logo
ADMA BiologicsADMA
32.4%-12.6pp

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Calculated from Cerus’s reported figures.

Based on trailing twelve months.

The official record: Cerus’s 10-Q, filed May 1, 2025, on SEC EDGAR. View the filing →

Ask your AI about Cerus's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's net margin?
Cerus (CERS) reported net margin of -9.8% in Q1 2025.
How has Cerus's net margin changed year-over-year?
Cerus's net margin increased by 41.1% year-over-year, from -16.6% to -9.8%.
What is the long-term trend for Cerus's net margin?
Over 4 years (2020 to 2024), Cerus's net margin has grown at a -33.3% compound annual growth rate (CAGR), from -52.4% to -10.4%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.